๐ŸŽ Black Friday: up to 50% off of annual plans
OK Biotech Co., Ltd. (TPE:4155)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
15.50
-0.70 (-4.32%)
Nov 20, 2026, 1:30 PM CST

OK Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,7231,5561,6701,1921,4841,263
Revenue Growth
5.09%-6.81%40.11%-19.65%17.42%-14.89%
Gross Profit
546.74429.25275.66196.88344.96186.83
Operating Income
293.08107.8957.21-12.06101.818.09
Net Income
251.0382.4593.982.95143.4643.46
Earnings Per Share
1.970.640.720.021.300.46
EPS Growth
274.82%-11.55%3121.00%-98.28%182.57%-68.83%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Patient Monitoring Equipment
1,8041,8861,2081,4931,267
Intersegment
-247.93-215.55-16.37-9.78-3.4
Total
1,5561,6701,1921,4841,263

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
424.35327.06290.5365.34636.64644.64
Total Debt
1,0681,013720.05331.95780.63733.86
Net Cash (Debt)
-643.87-686.09-429.5533.39-143.98-89.22
Net Cash Growth
------
Net Cash Per Share
-5.05-5.25-3.270.29-1.23-0.84

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
492.52318.8665.92.93240.5321.9
Capital Expenditures
-228.96-409.14-376.69-429.68-286.84-79.06
Free Cash Flow
263.56-90.28-310.79-426.74-46.31-57.16
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
31.73%27.58%16.51%16.52%23.25%14.79%
Operating Margin
17.01%6.93%3.43%-1.01%6.86%0.64%
Pretax Margin
19.05%6.67%7.61%0.67%11.84%3.65%
Profit Margin
14.57%5.30%5.63%0.25%9.67%3.44%
FCF Margin
15.30%-5.80%-18.61%-35.80%-3.12%-4.52%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3350.3350.3350.3351.2441.012
Dividend Per Share Growth
0%0%0%-73.11%22.94%-28.57%
Dividend Yield
2.16%2.07%1.43%1.20%4.63%4.28%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.8524.8732.001240.2618.4251.00
Forward PE
-16.3016.3016.3016.3016.30
PS Ratio
1.111.321.803.071.781.76